Trade

with

Siga Technologies Inc
(NASDAQ: SIGA)
AdChoices
=
1.39
0.00
0.00%
After Hours :
-
-
-

Open

1.40

Previous Close

1.39

Volume (Avg)

67.16k (558.11k)

Day's Range

1.38-1.45

52Wk Range

0.9901-3.87

Market Cap.

74.37M

Dividend Rate ( Yield )

-

Beta

1.94

Shares Outstanding

53.50M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 5.52M

    • Net Income

    • -17.18M

    • Market Cap.

    • 74.37M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -351.77

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.94

    • Forward P/E

    • -

    • Price/Sales

    • 16.67

    • Price/Book Value

    • 6.43

    • Price/Cash flow

    • 1.05

      • EBITDA

      • -23.13M

      • Return on Capital %

      • -8.06

      • Return on Equity %

      • -89.04

      • Return on Assets %

      • -8.06

      • Book Value/Share

      • 0.22

      • Shares Outstanding

      • 53.50M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 11.00

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • 0.82

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -32.60

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -7.31

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -518.73

            • 39.38

            • Net Profit Margin

            • -351.77

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 100.00

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -128.10

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.09

              • 0.76

              • Current Ratio

              • 15.45

              • 2.92

              • Quick Ratio

              • 11.88

              • 2.35

              • Interest Coverage

              • -30.81

              • 38.02

              • Leverage Ratio

              • 18.11

              • 2.21

              • Book Value/Share

              • 0.22

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -4.98

                • 243.90

                • P/E Ratio 5-Year High

                • -53.36

                • 634.30

                • P/E Ratio 5-Year Low

                • -3.37

                • 124.82

                • Price/Sales Ratio

                • 17.51

                • 9.29

                • Price/Book Value

                • 6.75

                • 8.39

                • Price/Cash Flow Ratio

                • 1.05

                • 49.75

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -89.04

                        (-121.60)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -8.06

                        (-42.20)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -60.46

                        (-118.80)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • 0.02

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -23.52M
                      Operating Margin
                      -426.07
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      1.05
                      Ownership

                      Institutional Ownership

                      52.43%

                      Top 10 Institutions

                      46.14%

                      Mutual Fund Ownership

                      1.21%

                      Float

                      73.11%

                      5% / Insider Ownership

                      4.29%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Bridgeway Ultra Small Company Market

                      •  

                        148,700

                      • 0.00

                      • 0.28

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        109,876

                      • 0.00

                      • 0.21

                      • Fidelity Spartan® Total Market Idx Fund

                      •  

                        72,968

                      • 0.00

                      • 0.14

                      • Putnam Small Cap Growth Fund

                      •  

                        68,900

                      • 0.00

                      • 0.13

                      • Putnam Dynamic Asset Allocation Gr Fund

                      •  

                        46,940

                      • 0.00

                      • 0.09

                      • EB DL Non-SL Market Completion Fund

                      •  

                        42,551

                      • 661.61

                      • 0.08

                      • Putnam Dynamic Asset Allocation Bal Fund

                      •  

                        31,255

                      • 0.00

                      • 0.06

                      • VALIC Company I Small Cap

                      •  

                        19,900

                      • 0.00

                      • 0.04

                      • USAA Extended Market Index Fund

                      •  

                        12,666

                      • 16.58

                      • 0.02

                      • Mellon Cap Market Completion Strategy

                      •  

                        11,982

                      • 12.97

                      • 0.02

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • MacAndrews & Forbes Holdings Inc

                      •  

                        13,105,838

                      • 0.00%

                      • 24.61

                      • Jet Capital Investors L P

                      •  

                        3,976,427

                      • 0.00%

                      • 7.43

                      • Newtyn Management LLC

                      •  

                        2,600,000

                      • +56.43%

                      • 4.86

                      • BlackRock Fund Advisors

                      •  

                        1,382,967

                      • -21.00%

                      • 2.58

                      • Gruber & Mcbaine Capital Management LLC

                      •  

                        1,098,777

                      • -6.48%

                      • 2.05

                      • Vanguard Group, Inc.

                      •  

                        1,048,402

                      • -5.45%

                      • 1.96

                      • Potomac Capital Management, Inc.

                      •  

                        452,776

                      • -0.66%

                      • 0.85

                      • Northern Trust Investments, N.A.

                      •  

                        395,870

                      • -16.42%

                      • 0.74

                      • Renaissance Technologies Corp

                      •  

                        286,205

                      • +97.11%

                      • 0.53

                      • J. Goldman & Co LP

                      •  

                        281,941

                      • 0.00%

                      • 0.53

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Distressed

                      Style

                      Small Value

                      Siga Technologies Inc is a pharmaceutical company specializing in the development and commercialization of pharmaceutical solutions for some of the most lethal disease-causing pathogens in the world: smallpox, Ebola, dengue, Lassa fe...morever and other dangerous viruses. The Company's discovers, develops, manufactures and commercializes drugs to prevent and treat these high-priority threats. Its product, Arestvyr (tecovirimat), also known as ST-246, is an orally administered antiviral drug that targets orthopoxviruses. The Company's product candidates include Dengue Antiviral, Anti-Arenavirus Drug, and Broad Spectrum Antiviral. It uses third parties known as Commercial Manufacturing Organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture Arestvyr. The Company's competitor...mores include most of the major pharmaceutical companies, each of which has financial, technical and marketing resources significantly greater than ours. Biotechnology and other pharmaceutical competitors include, but are not limited to, Sanofi Pasteur SA (formerly Acambis), GlaxoSmithKline, Bavarian Nordic AS, Chimerix Inc., and Emergent BioSolutions. The Company signed the U.S. Biomedical Advanced Research and Development Authority Contract pursuant to which the company agreed to deliver 2 million courses of Arestvyr to the Strategic Stockpile.lessless

                      Key People

                      Dr. Eric A. Rose, M.D.

                      Director/Chairman of the Board/CEO

                      Mr. Daniel (Dan) J. Luckshire

                      CFO/Chief Accounting Officer/Executive VP/Secretary

                      Mr. William J. Haynes , II

                      Executive VP/General Counsel

                      Dr. Dennis E. Hruby,PhD

                      Chief Scientific Officer/Vice President

                      Mr. James J. Antal

                      Director

                      • Siga Technologies Inc

                      • 660 Madison Avenue

                      • New York, NY 10065

                      • USA.Map

                      • Phone: +1 212 672-9100

                      • Fax: +1 212 697-3130

                      • siga.com

                      Incorporated

                      1995

                      Employees

                      34

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: